# Edwards Lifesciences opens initial facility in Shannon Free Zone

Edwards Lifesciences began operations at its initial site in the Shannon Free Zone, Ireland, as part of an €80 million investment plan that will create 600 jobs over several years. The facility will support development and manufacturing of structural heart disease and critical care monitoring products.

- Type: New facility
- Announced: 2018-08-08
- Where: Shannon Free Zone, Ireland, Ireland
- Value: $93.0M (80.0M EUR)
- Jobs: 600
- Starts operating: 8 Aug 2018
- Status: completed
- Products: structural heart disease products, critical care monitoring products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md)

## Sources

- [gov.ie](https://gov.ie/en/department-of-enterprise-tourism-and-employment/press-releases/first-day-of-business-for-edwards-lifesciences-initial-facility-in-the-shannon-free-zone/), 2018-08-07: "This is an exciting day for the team here at Edwards Lifesciences. Our first day of business represents many years of planning to invest in our global operations to support the development and manufacturing of our patient-focused innovations."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.